Why Analytical Purity Matters in Peptide Research
Purity data is the single most load-bearing number on a research peptide's documentation. A percentage on a label means nothing without a description of how that number was generated, what it excludes, and what method produced it. Two analytical techniques do almost all of the work in the peptide industry: high-performance liquid chromatography (HPLC) and mass spectrometry (MS). Understanding what each one actually measures, and where each one falls short, is what separates a researcher who can critically read a certificate of analysis (COA) from one who is simply trusting a number.
What "Purity" Means in an Analytical Context
In peptide chemistry, purity is a comparison, not an absolute property. It describes how much of a sample's detectable signal corresponds to the intended peptide sequence versus everything else present: truncated sequences left over from synthesis, deletion or insertion variants, oxidized side chains, residual solvents, counter-ions from the synthesis or purification process, and other synthesis-related impurities. A purity figure is only as meaningful as the method used to generate it, the detection window that method covers, and the reference standard it was compared against.
This is why a single number on a spec sheet, such as 99%+, is a starting point for evaluation rather than a conclusion. The relevant question is always: 99% of what, measured how?
High-Performance Liquid Chromatography (HPLC)
The General Mechanism
HPLC separates the components of a sample by pumping it, dissolved in a solvent, through a column packed with a stationary phase. Different molecules in the mixture interact with that stationary phase to different degrees based on properties like polarity and size, so they travel through the column at different speeds and exit at different times. Each component that exits is registered by a detector, most commonly a UV absorbance detector tuned to a wavelength where peptide bonds and aromatic residues absorb strongly.
The output is a chromatogram: a plot of detector signal against elapsed time. A pure sample produces one dominant, symmetric peak. A sample carrying synthesis byproducts produces smaller peaks before or after the main one, each representing a different molecular species that separated slightly differently on the column.
How Purity Is Calculated from HPLC Data
The most common purity calculation in this context is area-under-the-curve, sometimes called area normalization. The area of the main peak is divided by the total area of every peak in the chromatogram, then expressed as a percentage. This method is fast, reproducible, and widely used across the industry, but it carries an important limitation researchers should keep in mind: it assumes every compound in the sample absorbs light at the detection wavelength with roughly similar efficiency. Compounds that absorb weakly at that wavelength can be under-represented in the calculation, meaning the reported purity can look higher than the sample's true composition.
Mass Spectrometry (MS)
The General Mechanism
Where HPLC separates components by physical retention time, mass spectrometry identifies them by mass. A sample is ionized, and the resulting ions are measured according to their mass-to-charge ratio. The output is a spectrum showing peaks at specific mass values, each corresponding to a particular ionized species. For an intact peptide, the dominant peak should correspond to the expected molecular weight of the target sequence.
What Mass Spectrometry Confirms That HPLC Cannot
HPLC alone can tell a researcher that a sample is a single, well-resolved peak, but retention time does not prove identity. Two structurally distinct molecules can, in principle, co-elute at the same retention time under a given set of column and solvent conditions. Mass spectrometry addresses this by confirming that the mass of the dominant species matches the expected molecular formula of the intended peptide. This is why the two techniques are typically presented together on a rigorous COA: HPLC establishes how homogeneous the sample is, and MS establishes what the dominant component actually is.
Mass spectrometry is also the primary tool for detecting sequence-level problems that a chromatogram's shape alone would not necessarily flag, such as a single missing or substituted residue, since these changes shift the measured mass by a predictable, calculable amount.
Reading Purity and Mass Data on a Certificate of Analysis
When reviewing a COA, there are a few specific data points worth checking rather than skimming past the summary percentage:
- The stated purity percentage and the method it was derived from (HPLC area normalization is standard; note if a different method is used).
- The retention time and peak shape description, if provided, which indicate how cleanly the main component separated from any side products.
- The observed molecular weight from the mass spectrum compared against the theoretical molecular weight for the sequence.
- The lot or batch number tying the COA to the specific material it describes, since purity can vary between production lots of the same compound.
- The testing laboratory and the date the analysis was performed.
Compounds like BPC-157 and Semax each carry their own published testing data, and the same reading checklist applies regardless of which compound is on the page: check the method, check the lot match, and check that the mass matches the expected sequence before treating a purity figure as reliable.
What Purity Testing Does Not Tell You
It is worth being precise about the boundaries of what these two techniques establish, because it is easy to read more into a COA than the data supports.
- A high purity figure describes the chemical composition of the sample at the time of testing. It says nothing about how a compound behaves in any biological system, and a COA is not evidence of, and should never be interpreted as, any statement about effect or outcome.
- Purity testing does not verify sterility, endotoxin levels, or microbial contamination unless those specific assays were separately performed and reported. HPLC and MS are structural and compositional analyses, not sterility tests.
- A COA reflects one sample from one lot. It is not a guarantee about material from a different production run, even of the same compound from the same supplier.
- Not every product a supplier sells will necessarily have a COA available, and coverage can vary across a catalog. Absence of a published COA for a given item is a question to ask the supplier directly, not something to assume in either direction.
Evaluating Whether a Supplier's Testing Is Credible
Since purity data is only useful when the underlying testing is sound, part of evaluating any peptide source is evaluating how that testing was generated and disclosed. Questions worth asking before treating a COA as trustworthy:
- Is the COA specific to the lot being sold, identifiable by a matching lot number, rather than a generic document reused across multiple batches?
- Does the document specify the analytical method (HPLC, MS, or both) rather than presenting a bare percentage with no methodology?
- Is the testing performed by an independent third-party laboratory rather than solely in-house, and is that lab identified?
- Is the COA actually published and accessible for review, rather than described as available only on request?
- Does the reported molecular weight in the mass spectrum data match the theoretical value for the stated sequence?
A supplier that publishes lot-specific, method-labeled, third-party testing data gives a researcher something to actually evaluate. A bare purity number with no supporting method or lot reference gives a researcher nothing to check.
Applying This to a Research Workflow
For anyone selecting materials for a research protocol, the practical takeaway is to treat HPLC and MS data as complementary checks rather than redundant ones. HPLC-reported purity tells you how homogeneous a sample is relative to itself. Mass spectrometry tells you whether the dominant species in that sample is actually the sequence you intended to source. A COA that includes both, tied to a specific lot, with an identified testing laboratory, is materially more informative than a percentage alone.
Compounds such as GHK-Cu and MOTS-C are good examples of where this matters in practice, since their COAs, like those across the rest of the full catalog, are lot-specific documents rather than generic claims, and reading them with the checklist above is how a researcher turns a printed percentage into something they can actually rely on for material selection.
For laboratory research use only. Not for human consumption.